The effects of cognitive-behavioural therapy (CBT) on heart rate variability (HRV) in people with depression and/or anxiety disorders: A systematic review and meta-analysis.

Authors

Ahmad Alkout, Amirun Haqqim Bin Eldeen Husaini, Anoop Kadan, Valeria Parlatini, Samuele Cortese, Alessio Bellato

Published in

International journal of psychophysiology : official journal of the International Organization of Psychophysiology. Pages 113495. Oct 09, 2026. Epub Oct 09, 2026.

Abstract

Cognitive-behavioural therapy (CBT) is a widely used intervention for depression and anxiety. However, its effectiveness is typically evaluated using subjective self-report symptom scales, which are susceptible to bias. It is hypothesised that improvements in clinical symptoms following CBT may be accompanied by improvements in physiological regulation, particularly heart rate variability (HRV), which has been proposed as a marker of emotion regulation. We conducted a systematic review with meta-analysis to examine the effects of CBT on HRV in adults with depression and/or anxiety disorders.
Following a pre-registered protocol (PROSPERO: CRD420251040957), we searched Embase, PsycINFO, PubMed, and Web of Science for randomised controlled trials (RCTs) and non-randomised interventional studies involving adults with depression and/or anxiety in CBT, and reporting HRV before and after the intervention. Random-effects meta-analyses in R estimated pooled effect sizes (Hedges' g).
After screening 9713 records, we identified 12 studies; 5 RCTs were included in the meta-analysis, and the remaining 7 in the narrative review because they did not provide calculable effect sizes. Meta-analysis results found that adults randomised to CBT had significantly greater pre-to-post intervention increases in HF-HRV, LF-HRV, and SDNN-HRV. No significant changes were observed for the LF/HF ratio, RMSSD-HRV, and the HRV Triangular Index.
Our meta-analysis provides emerging evidence that CBT might significantly increase selected HRV indices, suggesting that physiological changes may accompany improvements in psychological symptoms. However, further high-quality research is needed to determine the clinical utility of HRV as a predictor of treatment response and a biomarker for treatment effectiveness.

PMID:
42854872
Bibliographic data and abstract were imported from PubMed on 10 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.